hepatitis B entecavir
Selected indexed studies
- Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis. (Viruses, 2023) [PMID:38005918]
- Entecavir for children and adults with chronic hepatitis B. (Cochrane Database Syst Rev, 2025) [PMID:40260837]
- Entecavir for the treatment of chronic hepatitis B infection. (Health Technol Assess, 2009) [PMID:19846026]
_Worker-drafted node — pending editorial review._
Connections
hepatitis B entecavir is a side effect of
Sources
- Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis. (2023) pubmed
- Entecavir for children and adults with chronic hepatitis B. (2025) pubmed
- Entecavir for the treatment of chronic hepatitis B infection. (2009) pubmed
- Renal function in entecavir-treated patients with chronic hepatitis B: a meta-analysis. (2024) pubmed
- Meta-analysis of the occurrence of hepatocellular carcinoma after the treatment of entecavir and tenofovir for chronic hepatitis B. (2023) pubmed
- Entecavir: a potent new antiviral drug for hepatitis B. (2003) pubmed
- Entecavir for the treatment of chronic hepatitis B virus infection. (2006) pubmed
- Entecavir: a new treatment option for chronic hepatitis B. (2006) pubmed
- Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy. (2020) pubmed
- Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy. (2024) pubmed